Immunization Insurance Coverage Vaccines 
STAT
JUNE 26, 2024
Makers of RSV vaccines for older adults saw their plans to try to expand usage hit a significant hurdle on Wednesday, when an expert committee that advises the Centers for Disease Control and Prevention on vaccines recommended changes that will likely see fewer older adults qualify for insurance coverage for these products.
The Checkup by Singlecare
MARCH 25, 2025
During the COVID-19 pandemic, broad immunization was key, so the Centers for Disease Control and Prevention (CDC) provided funding for free vaccines. That means people had to rely on their insurance plan for coverage. That means people had to rely on their insurance plan for coverage.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
OCTOBER 16, 2023
Two new immunizations promise to protect babies from respiratory syncytial virus – if people can find them , CNBC says. Providers are scrambling to offer a Pfizer vaccine, Abrysvo, to pregnant patients and a Sanofi monoclonal antibody, Beyfortus, to babies. Continue to STAT+ to read the full story…
Pharmacy Times
JULY 29, 2024
Providing immunization coadministration and assisting with insurance coverage are strategies to improve access.
The Checkup by Singlecare
JUNE 6, 2024
Arexvy is a single-dose vaccine recommended for the prevention of respiratory syncytial virus (RSV) in adults 60 years and older. Because the vaccines are so new, there are no generic alternatives, and the cost of Arexvy without insurance is around $636. However, most people can receive insurance coverage for Arexvy.
The Checkup by Singlecare
NOVEMBER 23, 2022
It’s considered an autoimmune disease because the immune system attacks the beta cells in the pancreas that produce insulin. Tzield works by binding to certain immune system cells and preventing them from attacking the beta cells in the pancreas, while also increasing cells that can help moderate the immune response.
The Checkup by Singlecare
JUNE 6, 2024
In response to this health concern, two brand-name vaccines, Arexvy and Abrysvo, have recently become available as preventive measures. They work by stimulating the body’s immune response to defend against RSV. These vaccines are designed for adults over the age of 60, a demographic vulnerable to severe RSV infections.
Expert insights. Personalized for you.
133 
Let's personalize your content